微血管侵犯对非乙非丙型肝炎肝细胞癌肝切除术后复发与生存的影响:多中心倾向性评分匹配分析
该多中心回顾性研究分析3308例根治性肝切除的肝细胞癌患者,其中439例非乙非丙型肝炎相关肝细胞癌(NBNC-HCC)按微血管侵犯(MVI)状态行倾向性评分匹配。结果显示MVI阳性患者无复发生存期和总生存期均显著更差,MVI独立预测术后复发和死亡,且与不利复发模式相关。
要点
- NBNC-HCC中MVI发生率低于病毒性肝炎相关HCC(31.44% vs 38.06%),但病毒性肝炎并非MVI独立危险因素。
- MVI阳性NBNC-HCC患者无复发生存期(中位30.0 vs 47.0个月)和总生存期均显著劣于MVI阴性者。
- MVI独立预测术后复发(HR=2.07)和死亡(HR=2.17),应纳入NBNC-HCC风险分层。
核心结论
- MVI独立预测NBNC-HCC根治性肝切除术后不良结局,与不利复发模式和生存降低相关。
- MVI的预后价值独立于病毒性肝炎,支持其用于该人群风险分层。
研究设计与样本
- 多中心回顾性研究,分析2012-2023年3308例接受根治性肝切除的HCC患者。
- 从总体队列中选取439例NBNC-HCC患者,按MVI状态分层并行倾向性评分匹配。
- 采用Cox回归模型和Kaplan-Meier分析(log-rank检验)比较无复发生存期和总生存期。
主要发现
- NBNC-HCC组MVI发生率低于HV-HCC组(31.44% vs 38.06%,P=0.007)。
- 病毒性肝炎不是MVI的独立危险因素(OR=1.20,95%CI 0.95-1.51,P=0.118)。
- 倾向性评分匹配后,MVI阳性NBNC-HCC患者无复发生存期更差(中位30.0 vs 47.0个月),总生存期更差(中位41.0个月 vs 未达到),均P<0.01。
- MVI独立预测术后复发(HR=2.07,95%CI 1.46-2.94)和死亡(HR=2.17,95%CI 1.45-3.26)。
- MVI阳性者同时肝内和肝外复发率更高(17.0% vs 11.4%),超出米兰标准复发更频繁(39.8% vs 22.9%)。
临床怎么用
- 对NBNC-HCC根治性肝切除患者,应关注MVI状态以进行术后风险分层。
- MVI阳性NBNC-HCC患者复发和死亡风险显著增高,需加强术后随访和复发监测。
局限性
- 本研究为回顾性研究,可能存在选择偏倚和未测量混杂因素。
- MVI阳性NBNC-HCC患者经倾向性评分匹配后样本量有限,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The epidemiological shift toward non-B non-C hepatocellular carcinoma (NBNC-HCC) highlights the need for identifying prognostic markers in this population. While microvascular invasion (MVI) has been established in hepatitis virus-related HCC (HV-HCC), its role in NBNC-HCC remains unclear. METHODS: This multicenter retrospective study analyzed 3308 patients with HCC undergoing curative resection (2012-2023). Risk factors for MVI were identified using logistic regression in the overall cohort. From this cohort, 439 patients with NBNC-HCC were stratified based on the MVI status and balanced using propensity score matching (PSM). Cox regression models and Kaplan-Meier analysis with log-rank test were employed to compare recurrence-free survival (RFS) and overall survival (OS) between MVI-positive and MVI-negative subgroups. RESULTS: The incidence of MVI was lower in the NBNC-HCC group compared to the HV-HCC group (31.44% vs. 38.06%, P = 0.007), but viral hepatitis was not an independent risk factor for MVI (OR = 1.20, 95% CI 0.95-1.51, P = 0.118). After PSM, patients with MVI-positive NBNC-HCC had significantly worse RFS (median 30.0 vs. 47.0 months) and OS (median 41.0 months vs. not reached) compared to MVI-negative patients (both P < 0.01). MVI independently predicted postoperative recurrence (HR = 2.07, 95% CI 1.46-2.94) and mortality (HR = 2.17, 95% CI 1.45-3.26). MVI-positive cases also demonstrated adverse recurrence patterns, characterized by higher rates of simultaneous intrahepatic and extrahepatic recurrence (17.0% vs. 11.4%) and more frequent recurrence beyond the Milan criteria (39.8% vs. 22.9%). CONCLUSION: MVI independently predicts adverse outcomes in NBNC-HCC, associated with adverse recurrence and reduced survival. The prognostic value of MVI is independent of viral hepatitis, supporting its importance for risk stratification in this population.
引用
- Feng C, Zhang TC, Wang YT, et al. The impact of microvascular invasion in tumor recurrence and survival after liver resection for non-B non-C hepatocellular carcinoma: a multicenter, propensity score-matched analysis. Surg Endosc. 2026. PMID: 41644643. doi:10.1007/s00464-026-12586-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。